BackRohto Pharmaceutical ,Ltd. Overview

Rohto Pharmaceutical ,Ltd. Total Current Liabilities

Latest total current liabilities for RPHCF: $99B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$99.04B
↓ 4.53% YoYΔ $-4.70B vs prior year quarter

Peer trimmed avg / median

Loading

Rohto Pharmaceutical ,Ltd. Total Current Liabilities History

Loading

Rohto Pharmaceutical ,Ltd. vs. peers: Total Current Liabilities Comparison

Loading

Rohto Pharmaceutical ,Ltd. Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rohto Pharmaceutical ,Ltd. (RPHCF) FAQ

Rohto Pharmaceutical ,Ltd. (RPHCF) currently reports a total current liabilities of $99B as of September 2026. That compares with $100B in the prior-year period — down 4.5% year over year. Use the charts on this page to explore Rohto Pharmaceutical ,Ltd.'s total current liabilities history and peer comparisons.

Rohto Pharmaceutical ,Ltd.'s total current liabilities decreased from $100B to $99B — a 4.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rohto Pharmaceutical ,Ltd. reported $99B in total current liabilities as of September 2026. That compares with $100B in the prior-year period — down 4.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $99B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rohto Pharmaceutical ,Ltd., and consider following RPHCF for alerts when major investors trade the stock.